Bosh sahifaEXAS • NASDAQ
add
Exact Sciences Corp
Yopilish kursi
101,82 $
Kunlik diapazon
101,63 $ - 101,88 $
Yillik diapazon
38,88 $ - 101,95 $
Bozor kapitalizatsiyasi
19,30 mlrd USD
Oʻrtacha hajm
8,42 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 850,74 mln | 20,05% |
Joriy xarajat | 584,94 mln | 14,70% |
Sof foyda | -19,59 mln | 48,76% |
Sof foyda marjasi | -2,30 | 57,41% |
Har bir ulushga tushum | 0,24 | 287,35% |
EBITDA | 54,87 mln | 51,27% |
Amaldagi soliq stavkasi | -10,35% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,00 mlrd | -1,77% |
Jami aktivlari | 5,90 mlrd | -12,57% |
Jami passivlari | 3,40 mlrd | -3,94% |
Umumiy kapital | 2,50 mlrd | — |
Tarqatilgan aksiyalar | 189,47 mln | — |
Narxi/balansdagi bahosi | 7,71 | — |
Aktivlardan daromad | -0,04% | — |
Kapitaldan daromad | -0,05% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -19,59 mln | 48,76% |
Operatsiyalardan naqd pul | 219,92 mln | 58,54% |
Sarmoyadan naqd pul | -86,45 mln | -5,80% |
Moliyadan naqd pul | -1,53 mln | -577,88% |
Naqd pulning sof oʻzgarishi | 131,94 mln | 124,96% |
Boʻsh pul | 194,64 mln | 80,56% |
Haqida
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion. Wikipedia
CEO
Tashkil etilgan
1-yan, 1995
Xodimlar soni
6 950
